The Quinolones
Overview
Authors
Affiliations
The molecular basis of activity, chemistry, microbiology, and pharmacology of the new fluoroquinolones is reviewed in this article. Areas of clinical use are analyzed with specific reference to efficacy, development of resistance, and potential for toxicity.
Use of fluoroquinolone antimicrobial agents by cardiovascular and cardiopulmonary surgeons.
Neu H Tex Heart Inst J. 1990; 17(1):12-21.
PMID: 15227184 PMC: 324895.
Pharmacokinetic considerations in the treatment of bacterial keratitis.
Callegan M, OCallaghan R, Hill J Clin Pharmacokinet. 1994; 27(2):129-49.
PMID: 7955776 DOI: 10.2165/00003088-199427020-00005.
Comparative in vitro activity of the new fluoroquinolone BMY-40062.
Chin N, Neu H Eur J Clin Microbiol Infect Dis. 1990; 9(8):620-4.
PMID: 2120060 DOI: 10.1007/BF01967221.
Do we need an intravenous fluoroquinolone?.
Maddix D, Warner L West J Med. 1992; 157(1):55-9.
PMID: 1413744 PMC: 1021906.
The quinolones. An overview of their pharmacology.
Fitton A Clin Pharmacokinet. 1992; 22 Suppl 1:1-11.
PMID: 1319865 DOI: 10.2165/00003088-199200221-00003.